2025 Q4 -tulosraportti
Vain PDF
23 päivää sitten
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·6 t sitten · MuokattuImportant timeline May 8 - VWAP period starts. May 8–22 - Daily price development affects the exercise price. May 11–15 - Possible hype/newsflow. May 22 - After closing the exercise price is announced. May 26 - Exercise period starts. June 3 - Last trading day for warrants. June 9 - Warrants expire. Approx. June 12 - mid-June new shares come in.
·2 min sitten · MuokattuYou should stop these verbal abuses, Epstein. There are victims of them.
·9 t sittenLAST TRADING DAY BEFORE BOSTON. THE STARTER MOTOR IS NOW BEING FIRED UP. 🧬🔥 Tomorrow is no ordinary Friday on the stock exchange. It is the very last opportunity the market has to position itself before the curtain rises for ASGCT. After tomorrow, the window closes. Next week we are on the field's biggest global stage. That's where Big Pharma sits in the front row. That's where 60x expression and 10x lower dose will be put on the table in front of the industry's most important decision-makers. That's where Circio goes from being a "Norwegian microcap" to being showcased as an international platform candidate. People have been talking about Boston for months. Now we are here. Those who are still sitting on the fence waiting for "more proof" are playing an extremely dangerous game with risk/reward. In biotech, expectations are priced in before the stage lights come on, not after the applause has died down. Tomorrow's trading will be about one thing: Who really dares to stay out when Circio takes the spotlight and presents "The Mechanics"? The rocket is on the ramp. Tomorrow the countdown truly begins. We know what we own. ♟️🧱🍷
·10 t sittenWhat happens to the actual stock price when a discount on subscription rights kicks in. Will it affect the actual price?
·8 t sittenThere are 238 million shares in the company. TR provides the opportunity for a maximum of 67 million new shares. These come with a 20% discount. The theoretical new price is the weighted average of these - in other words, marginal impact. In addition, CRNA is a company that needs capital (despite good financing for a while now). It is a company that burns cash and therefore cash inflow is always welcome and something that is necessary for long-term operations. Thus, a delta positive effect. Makes sense?
·10 t sittenCan't stop thinking about all the good contributions that have appeared on this page just in the short time I've been here. But also thinking a lot about stock psychology regarding circio. You see all the hyped posts "acquisition coming soon", "It can't go wrong", "this platform is better than the others, so this one will be bought", "rises Monday". etc. etc. You look at the annual chart and see it has risen 1165%. Why not have a piece of the pie? Do your own analysis and follow your gut feeling. This is a forum for sparring and at times nonsense and jesting. But I now see a cult-like tendency like "new context" on the MPC page. So I can be concerned that more people are being hyped up to buy and form a kind of solidarity in it. Pump and dump risk. A lot of stock psychology in this.
·9 t sittenA classic thing, if one has an early entry, is that one sells when euphoria rises. Then one takes money off the table, and eliminates potential further risk. Things can continue to rise, but one has taken the gain, and has secured it. But often, when euphoria becomes evident, one takes money off the table. Those who are new will of course not take the money off the table since they are new hands, they are the ones who make those who already have returns cash in on it.·8 t sittenThat's probably also a point, but it doesn't nullify what I said. We're talking about two different things here.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
Vain PDF
23 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·6 t sitten · MuokattuImportant timeline May 8 - VWAP period starts. May 8–22 - Daily price development affects the exercise price. May 11–15 - Possible hype/newsflow. May 22 - After closing the exercise price is announced. May 26 - Exercise period starts. June 3 - Last trading day for warrants. June 9 - Warrants expire. Approx. June 12 - mid-June new shares come in.·2 min sitten · MuokattuYou should stop these verbal abuses, Epstein. There are victims of them.
- ·9 t sittenLAST TRADING DAY BEFORE BOSTON. THE STARTER MOTOR IS NOW BEING FIRED UP. 🧬🔥 Tomorrow is no ordinary Friday on the stock exchange. It is the very last opportunity the market has to position itself before the curtain rises for ASGCT. After tomorrow, the window closes. Next week we are on the field's biggest global stage. That's where Big Pharma sits in the front row. That's where 60x expression and 10x lower dose will be put on the table in front of the industry's most important decision-makers. That's where Circio goes from being a "Norwegian microcap" to being showcased as an international platform candidate. People have been talking about Boston for months. Now we are here. Those who are still sitting on the fence waiting for "more proof" are playing an extremely dangerous game with risk/reward. In biotech, expectations are priced in before the stage lights come on, not after the applause has died down. Tomorrow's trading will be about one thing: Who really dares to stay out when Circio takes the spotlight and presents "The Mechanics"? The rocket is on the ramp. Tomorrow the countdown truly begins. We know what we own. ♟️🧱🍷
- ·10 t sittenWhat happens to the actual stock price when a discount on subscription rights kicks in. Will it affect the actual price?·8 t sittenThere are 238 million shares in the company. TR provides the opportunity for a maximum of 67 million new shares. These come with a 20% discount. The theoretical new price is the weighted average of these - in other words, marginal impact. In addition, CRNA is a company that needs capital (despite good financing for a while now). It is a company that burns cash and therefore cash inflow is always welcome and something that is necessary for long-term operations. Thus, a delta positive effect. Makes sense?
- ·10 t sittenCan't stop thinking about all the good contributions that have appeared on this page just in the short time I've been here. But also thinking a lot about stock psychology regarding circio. You see all the hyped posts "acquisition coming soon", "It can't go wrong", "this platform is better than the others, so this one will be bought", "rises Monday". etc. etc. You look at the annual chart and see it has risen 1165%. Why not have a piece of the pie? Do your own analysis and follow your gut feeling. This is a forum for sparring and at times nonsense and jesting. But I now see a cult-like tendency like "new context" on the MPC page. So I can be concerned that more people are being hyped up to buy and form a kind of solidarity in it. Pump and dump risk. A lot of stock psychology in this.·9 t sittenA classic thing, if one has an early entry, is that one sells when euphoria rises. Then one takes money off the table, and eliminates potential further risk. Things can continue to rise, but one has taken the gain, and has secured it. But often, when euphoria becomes evident, one takes money off the table. Those who are new will of course not take the money off the table since they are new hands, they are the ones who make those who already have returns cash in on it.·8 t sittenThat's probably also a point, but it doesn't nullify what I said. We're talking about two different things here.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
2025 Q4 -tulosraportti
Vain PDF
23 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·6 t sitten · MuokattuImportant timeline May 8 - VWAP period starts. May 8–22 - Daily price development affects the exercise price. May 11–15 - Possible hype/newsflow. May 22 - After closing the exercise price is announced. May 26 - Exercise period starts. June 3 - Last trading day for warrants. June 9 - Warrants expire. Approx. June 12 - mid-June new shares come in.·2 min sitten · MuokattuYou should stop these verbal abuses, Epstein. There are victims of them.
- ·9 t sittenLAST TRADING DAY BEFORE BOSTON. THE STARTER MOTOR IS NOW BEING FIRED UP. 🧬🔥 Tomorrow is no ordinary Friday on the stock exchange. It is the very last opportunity the market has to position itself before the curtain rises for ASGCT. After tomorrow, the window closes. Next week we are on the field's biggest global stage. That's where Big Pharma sits in the front row. That's where 60x expression and 10x lower dose will be put on the table in front of the industry's most important decision-makers. That's where Circio goes from being a "Norwegian microcap" to being showcased as an international platform candidate. People have been talking about Boston for months. Now we are here. Those who are still sitting on the fence waiting for "more proof" are playing an extremely dangerous game with risk/reward. In biotech, expectations are priced in before the stage lights come on, not after the applause has died down. Tomorrow's trading will be about one thing: Who really dares to stay out when Circio takes the spotlight and presents "The Mechanics"? The rocket is on the ramp. Tomorrow the countdown truly begins. We know what we own. ♟️🧱🍷
- ·10 t sittenWhat happens to the actual stock price when a discount on subscription rights kicks in. Will it affect the actual price?·8 t sittenThere are 238 million shares in the company. TR provides the opportunity for a maximum of 67 million new shares. These come with a 20% discount. The theoretical new price is the weighted average of these - in other words, marginal impact. In addition, CRNA is a company that needs capital (despite good financing for a while now). It is a company that burns cash and therefore cash inflow is always welcome and something that is necessary for long-term operations. Thus, a delta positive effect. Makes sense?
- ·10 t sittenCan't stop thinking about all the good contributions that have appeared on this page just in the short time I've been here. But also thinking a lot about stock psychology regarding circio. You see all the hyped posts "acquisition coming soon", "It can't go wrong", "this platform is better than the others, so this one will be bought", "rises Monday". etc. etc. You look at the annual chart and see it has risen 1165%. Why not have a piece of the pie? Do your own analysis and follow your gut feeling. This is a forum for sparring and at times nonsense and jesting. But I now see a cult-like tendency like "new context" on the MPC page. So I can be concerned that more people are being hyped up to buy and form a kind of solidarity in it. Pump and dump risk. A lot of stock psychology in this.·9 t sittenA classic thing, if one has an early entry, is that one sells when euphoria rises. Then one takes money off the table, and eliminates potential further risk. Things can continue to rise, but one has taken the gain, and has secured it. But often, when euphoria becomes evident, one takes money off the table. Those who are new will of course not take the money off the table since they are new hands, they are the ones who make those who already have returns cash in on it.·8 t sittenThat's probably also a point, but it doesn't nullify what I said. We're talking about two different things here.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Välittäjätilasto
Dataa ei löytynyt